Irinotecan Hydrochloride recalls
Irinotecan Hydrochloride products have been recalled 4 times, most recently on 24 Jun 2020. The recalling company is usually Hikma Pharmaceuticals USA. The most common reason is potency & assay.
Total recalls4since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 Jun 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why irinotecan hydrochloride is recalled
Companies
Product types
By year
All irinotecan hydrochloride recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Irinotecan HCL Injection, USP, 100mg/ vials recalledIrinotecan Hydrochloride | Hikma Pharmaceuticals USA | Other | Nationwide |
| Drug | CLASS II | Irinotecan HCL Injection, USP, 100mg/ vials recalledIrinotecan Hydrochloride | Hikma Pharmaceuticals USA | Other | Nationwide |
| Drug | CLASS II | Irinotecan Hydrochloride Injection, 40 mg/ (20 mg/mL) recalledIrinotecan Hydrochloride | West-Ward Pharmaceutical | Potency & Assay | Nationwide |
| Drug | CLASS II | Irinotecan Hydrochloride Injection, 100 mg/ (20 mg/mL) recalledIrinotecan Hydrochloride | West-Ward Pharmaceutical | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.